Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Initially conceptualized as a therapeutic for neurodegenerative disorders such as Alzheimers and Parkinsons disease, its primary mechanism of action involves high-affinity binding to hepatocyte growth factor (HGF) and its cognate receptor c-Met
200 doses per vial at this configuration
In vitro studies demonstrate that treatment with the peptide BPC-157 increases GHR mRNA and protein levels in a dose- and time-dependent manner, enhancing the fibroblasts responsiveness to growth hormone and promoting cell proliferation essential for tendon healing
orthotopic: *p = 0.0412
ISBN 0-486-23729-X
Physical and emotional stress can also reduce typical levels
US$ 28.47
US$ 21.63
US$ 21.15
US$ 26.61
